PERCHERON THERAPEUTICS LIMITED
Who is PERCHERON THERAPEUTICS LIMITED?
Percheron Therapeutics Limited (ASX: PER) is an international biotechnology company focused on the development of novel therapies for rare diseases. The company’s lead program is ATL1102, an antisense oligonucleotide targeting the CD49d receptor. ATL1102 is currently the subject of an ongoing inte...See more
Industry & Specialities
Others
Countries of Operation
Australia
Headquarters:
Australia
Company Type:
MNC / Large Enterprise
Company size:
1-10 Employees
Year Founded:
2000 (26 years)
Address:
L30, 35 COLLINS STREET; MELBOURNE, VICTORIA 3000, AU
Employees by Department
- The Rest (5)
- Total (5)
Key Decision Makers
Sue Turner
Finance & Administration Manager
Louise Tremper
Clinical Program Manager
Andrew Mckenzie
Clinical Development Director
Charmaine Gittleson
Chair Of The Board Of Directors
Employees by Seniority
C-level
3employees
Senior
0employees
Non-managers
0employees
Financials
LOW
spending power
Funding Status
Publicly listed on stock exchange
Associated Legal Entities
0 entities
Discover More Companies
Lookalike companies
Featured Lists
- SMEs in Singapore
- MNCs / Large Enterprises in Singapore
Frequently Asked Questions (FAQ)
- How long has PERCHERON THERAPEUTICS LIMITED been operating for?
- What is the funding status of PERCHERON THERAPEUTICS LIMITED?
- Where is PERCHERON THERAPEUTICS LIMITED's headquarter?
- What PERCHERON THERAPEUTICS LIMITED's spending power?
- Does PERCHERON THERAPEUTICS LIMITED have a presence in the domain it operates in?